- Report
- March 2024
- 198 Pages
Global
From €3241EUR$3,374USD£2,766GBP
€3601EUR$3,749USD£3,074GBP
- Report
- July 2022
- 120 Pages
Global
From €2401EUR$2,500USD£2,050GBP
- Clinical Trials
- January 2022
- 60 Pages
Global
From €1441EUR$1,500USD£1,230GBP
- Report
- June 2022
- 245 Pages
Global
From €5541EUR$5,769USD£4,730GBP
- Report
- August 2019
- 309 Pages
Global
From €5158EUR$5,370USD£4,403GBP
Lactamase is an enzyme that hydrolyzes β-lactam antibiotics, such as penicillins and cephalosporins, and is used to treat bacterial infections. It is a type of β-lactamase, which is an enzyme that breaks down the β-lactam ring of the antibiotic, rendering it ineffective. Lactamase is produced by many bacteria, including Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. It is also produced by some fungi, such as Aspergillus fumigatus.
The lactamase market is a growing industry, with a wide range of applications in the medical and pharmaceutical industries. It is used to treat bacterial infections, as well as to develop new antibiotics and other drugs. It is also used in research and development, to study the structure and function of enzymes.
Some companies in the lactamase market include Merck, Novozymes, Sigma-Aldrich, and Roche. Show Less Read more